Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/30053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBOUMAZA HANA-
dc.contributor.authorENAICHOUCHE IKRAM-
dc.date.accessioned2024-09-09T09:49:27Z-
dc.date.available2024-09-09T09:49:27Z-
dc.date.issued2024-
dc.identifier.citationblida1fr_FR
dc.identifier.urihttps://di.univ-blida.dz/jspui/handle/123456789/30053-
dc.description4.540.1.1242 ; 99pfr_FR
dc.language.isofrfr_FR
dc.publisherblida1fr_FR
dc.subjectContribution à l’étude de l’évaluation Des Risques Liés à La Fabrication Des Médicaments Cytotoxiques Et Hautementfr_FR
dc.titleContribution à l’étude de l’évaluation Des Risques Liés à La Fabrication Des Médicaments Cytotoxiques Et Hautement Actifsfr_FR
Appears in Collections:Mémoires de Master

Files in This Item:
File Description SizeFormat 
PFE M2 pharmacie industrielle 2024 corrigé.pdf1,26 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.